This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
The tri-county tech scene is buzzing at a rate unseen since the dot-com boom of the late 1990s and early 2000s. Invoca, the Santa Barbara-based telephone marketing automation firm, has joined the ranks of companies in the Tri-Counties on the path to an IPO. Invoca’s announcement June 25 capped a whirlwind spring for tri-county tech Read More →
Westlake Village-based Qualstar Corp., a manufacturer of data and archive storage solutions and high efficiency power supplies, released the Qualstar Q1 on Thursday. The Qualstar Q1 is a archive solution to transfer and archive data. Qualstar describes the product as a cost effective solution for people who want to restore archives or review data. The Read More →
Goleta-based Transphorm has received a $70 million investment. Transphorm, an early stage semi-conductor company focused on creating ways to convert electricity more efficiently, announced the investment Monday, which was led by global investment firm KKR. Transphorm will use the money to fund product innovation and expansion projects. “By merging the technological leadership of Transphorm with Read More →
For San Luis Obispo’s MindBody, reality has set in. The party is over. After early excitement about its initial public offering Friday, reality set in when shares plummeted about 17.4 percent by the end of the day. MindBody shares were rebounding slightly Monday morning. MindBody raised $101 million by selling 7.2 million shares at $14 Read More →
Westlake Village-based Cynvenio Biosystems raised $25.5 million in Series B equity financing Wednesday. Cynvenio’s LiquidBiopsy technology allows doctors to access populations of rare cancer cells in whole blood. At the same time, it allows doctors to analyze complex characteristics of cancers in a single blood sample. The investment was led by Livzon Pharmaceutical Group, which Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
